Precision Biosciences DL !....Zombie oder..
Zugriffe: 1.326 / Heute: 47
|PRECISION BIOSCIE.:||13,26 $||+0,00%|
|Perf. seit Threadbeginn:||+72,43%|
"Mr. Buehler has over thirty years of experience in the healthcare industry. He spent the majority of his career with Alcon Laboratories, a publicly traded ophthalmology-focused healthcare company headquartered in Fort Worth, Texas. At Alcon, Mr. Buehler rose through the commercial organization, eventually becoming CEO, leading the company’s sale to Novartis and subsequently serving as Alcon division head within Novartis. He will assume the chairmanship of Precision’s Nominating and Corporate Governance Committee (replacing Mr. Kane), and will also join the company’s Audit Committee (replacing Dr. Adelman)."
CRSP Market Cap 2.94B CRISPR Therapeutics AG
DTIL Market Cap 453.90M Precision BioSciences, Inc.
NTLA Market Cap 669.96M Intellia Therapeutics, Inc.
EDIT Market Cap 1.16B Editas Medicine, Inc.
SRPT Market Cap 7.28B Sarepta Therapeutics, Inc.